Impact of Exercise Intensity on Fitness, Extracellular Vesicles, Inflammation, and Metabolism

NCT ID: NCT06398548

Last Updated: 2024-05-08

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-05-01
• Study Completion Date: 2025-03-01

Brief Summary

Introduction

This study investigates the effects of different intensities of indoor cycling on various health measures. Participants will perform a maximal cycling test to determine their maximal fitness - a strong predictor of overall health - before and after a 6-week training intervention. Blood samples will also be obtained to look at various physiological markers related to extracellular vesicles, inflammation, and metabolism.

Who can participate?

Healthy young adults who between 18 and 40, are free of immune disease, with a normal body mass index can join this study. They will be divided into three groups:

• One group will ride a bike at a moderate pace.
• Another group will ride a bike at a slightly harder pace.
• The third group won't change their usual daily activities and will continue living as they normally do.

What does the study involve?

Each exercise session aims to burn a specific amount of calories: 350 for males and 300 for females. Participants cycle 3 times a week for 6 weeks. At the end, we'll repeat the bike test and take another blood sample to see if there have been any changes due to the exercise.

Why is this research being done?

The researchers want to see how different intensities of exercise impact health and fitness. This may help people make better choices about how much and what type of exercise they should do.

What happens after the study?

Researchers will analyze the data from the study and see if any differences exist between the protocols. If the participant is interested, we will also provide their blood test results, and the results from their max test.

Detailed Description

This study is being carried out by the Exercise Metabolism and Inflammation Laboratory at the University of British Columbia campus in Kelowna, British Columbia. Participants who have met the inclusion criteria will first complete an informed consent form. Participants will also complete forms to determine their level of activity. Females will also complete a menstrual cycle questionnaire - but will not be required to start on a particular day in their cycle. Participants will have their anthropometrics recorded (height, weight, body composition), will provide a fasted blood sample, and undergo a maximal staged exercise test to determine their lactate threshold and their maximal oxygen uptake (VO2peak).

The blood test will be used to measure various markers. First, whole blood will be analyzed on a standard hematology analyzer to determine white blood cell counts, red blood cell counts, hemoglobin and platelets. Secondly, blood samples will be spun down to platelet poor plasma and stored for batch analysis. Analysis of plasma will include measurement of plasma cytokines: Interleukin (IL)-6, IL-10, IL-1 receptor agonist, tumor necrosis factor alpha (TNF-alpha) and plasma extracellular vesicles. Extracellular vesicles (EVs) will be isolated using size exclusion chromatography (SEC) and measured for size and concentration using tunable resistive pulse sensing (Izon Exoid, Izon USA). EV phenotype and origin will be determined using nano-flow cytometry (CytoFlex S, Beckman Coulter, USA). EV micro ribonucleic acid (miRNA) will be determined by extracting miRNA from isolated and concentrated EVs (high speed centrifugation of 25,000 x g for 1 hour at 20 degrees Celsius). Extracted miRNA will be measured using PCR (BioRad, USA).

The maximal exercise will occur on a stationary cycle ergometer (Lode Excalibur, Lode, The Netherlands). The ergometer is adjusted to be ideal for each participant. Participants are fitted with a chest strap heart rate monitor (Polar, Finland) and fitted with a face mask to collect to determine the amount of O2 consumption, and CO2¬ production. Lactate measures will be collected from fingertip capillary blood and measured with a lactate analyzer (Nova, USA) during the last 30 seconds of each stage, as is a rating of perceived exertion (RPE). The protocol involves remaining stationary on the ergometer for 2 minutes. Following baseline measures, participants will complete 2 minutes of warm up at 50 watts (W), and then 3-minute stages at consecutively higher workloads (20W increases for females, 30W increases for males). Participants cycle at 60 - 80 revolutions per minute (rpm) for as long as they can. Once they fall below, or cannot maintain a minimum of 50rpm, the test is terminated.

Following the test, the lactate threshold determined as a weighted combination of the log-log method, and Dmax method will be calculated. Weighting consists of 75% of the log-log value and 25% of the Dmax value as calculated in the "lactater" R package. Using their lactate thresholds, specific exercise prescriptions are determined.

Group randomization is completed using a 2:2:1 ratio of moderate intensity continuous training (MICT), heavy intensity continuous training (HICT) and control (CTRL). A power calculation using an alpha of 0.05, power of 0.8 and a medium effect size using changes in VO2peak within the literature suggest that 52 participants will need to complete the study.

For the MICT group, participants will cycle at the resistance associated with 70% of the resistance at their first lactate threshold (LT1) such that if their lactate threshold occurred at 110W, they would initially cycle at 77W (0.7 * 110W). In the HICT group, the participants will cycle at the delta 10% of their lactate threshold and highest achieved resistance at the end of the test. As an example, a participant with a lactate threshold at 110W, who made it to 260W, would cycle at 125W (260W - 110W = 150W), (150W * 0.1 = 15W), (15W + 110W= 125W). Each allocation is matched for energy expenditure, such that males will expend 350 kcals and females will expend 300 kcals.

As the participant progresses through the trial, they will experience an increase in resistance as they adapt to the training protocol. The lactate value associated with their allocation will be maintained throughout. For example, in the 2nd week, if their lactate falls by 10% or more, their resistance will be increased by 10%. The time of each session will also be modified based on the VO2 value associated with their threshold test.

Following the last session of their participation, we will schedule their post test to fall on what would normally be date of their next session. Furthermore, all post testing is completed between 48 and 72 hours following their last session. The post-test and pre-test are identical in nature.

Conditions

Exercise Training

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: FACTORIAL
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

Control Group

This group undergoes the same testing protocols as the intervention groups, but is prescribed no additional exercise.

Group Type: OTHER

Control Group

Intervention Type: OTHER

Participants continue with their lifestyle as usual, with no modification to lifestyle, or exercise habits.

Moderate Intensity Continuous Training

In this allocation, participants cycle at 70% the resistance associated with their lactate threshold

Group Type: EXPERIMENTAL

Moderate Intensity Continuous Training

Intervention Type: OTHER

This group cycles at 70% of the resistance associated with their first lactate threshold.

Heavy Intensity Continuous Training

In this allocation, participants cycle at the resistance associated with their lactate threshold, with an additional 10% of the difference between their LT and maximal achieved watts during the test.

Group Type: EXPERIMENTAL

Heavy Intensity Continuous Training

Intervention Type: OTHER

This group cycles at 10% of the difference between the resistance associated with their lactate threshold, and maximal achieved watts, added to the resistance associated with their lactate threshold.

Interventions

Control Group

Participants continue with their lifestyle as usual, with no modification to lifestyle, or exercise habits.

Intervention Type: OTHER

Moderate Intensity Continuous Training

This group cycles at 70% of the resistance associated with their first lactate threshold.

Intervention Type: OTHER

Heavy Intensity Continuous Training

This group cycles at 10% of the difference between the resistance associated with their lactate threshold, and maximal achieved watts, added to the resistance associated with their lactate threshold.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Are between the ages of 18 and 40 years old.
• Have a body mass index (BMI) between 18.5 and 30 kg/m^2.
• Perform between 60 and 200 minutes of aerobic physical activity per week.
• Do not have a history of cardiovascular disease or diabetes.

Exclusion Criteria

• Require immunomodulatory medication to treat an auto-immune disease, or rely heavily on over the counter anti-inflammatory medications (e.g., Advil).
• Have a metabolic condition such as diabetes.
• Have hypertension (blood pressure > 160/90 mmHg).
• Are uncomfortable with blood sampling.
• Are an elite endurance athlete, or training specifically for an endurance event (>3 structured aerobic training sessions, or >150 min of specific aerobic-based/endurance training per week).
• Adhere to an extreme diet (e.g., ketogenic diet, time restricted feeding).
• Smoke cigarettes

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of British Columbia

OTHER

Sponsor Role: lead

Responsible Party

Jonathan Little

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

ART 115

Kelowna, British Columbia, Canada

Site Status: RECRUITING

Countries

Canada

Central Contacts

Jonathan P Little, PhD

Role: CONTACT

jonathan.little@ubc.ca

2508079876

Garett S Jackson, MSc.

Role: CONTACT

garett.jackson@ubc.ca

2508079122

Other Identifiers

H22-02823

Identifier Type: -

Identifier Source: org_study_id